Analytica names new director

Analytica (ASX:ALT) has appointed 30-year biotechnology veteran Carl Stubbings to the role of non-executive director, effective today.

Stubbings is currently chief business officer of Benitec Biopharma (ASX:BLT), where he focuses on commercialisation efforts including licensing and partnership agreements. He is also a non-executive director for cancer diagnostics company Sienna Diagnostics.

Before joining these companies, Stubbings held roles including VP of sales and marketing for Focus Diagnostics - a subsidiary of US pathology provider Quest Diagnostics - and a founder and senior VP of the US division of Brisbane-based virus test developer Panbio (now part of Alere).

“Carl’s appointment strengthens our board’s marketing experience, particularly in the USA, positioning Analytica ideally as we move toward the launch of PeriCoach in 2014 in the largest healthcare market in the world,” Analytica chairman Dr Michael Monsour commented.

PeriCoach is Analytica’s medical device for strengthening the pelvic floor muscles in women with urinary incontinence.

The device is designed to transmit data via Bluetooth to users’ smartphones, tablets or laptops, to allow them to monitor progress and share the results with medical professionals.